Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of multiple intranasal doses of ketorolac tromethamine for postoperative pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine intranasal (ketorolac tromethamine)

Snippet

Sponsor: Egalet Ltd | Conditions: Postoperative Pain | Phase 3 | Status: COMPLETED